Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × penpulimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Rectal Neoplasms 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Paraganglioma, Extra-Adrenal 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Osteosarcoma 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma 1 Gynecological Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Diseases 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Oxaliplatin 245 Fluorouracil 243 Capecitabine 198 Leucovorin 192 Irinotecan 136 Radiotherapy 124 Bevacizumab 102 Cetuximab 71 Surgical Procedures, Operative 48 Folfox protocol 46 Neoadjuvant Therapy 43 Drug Therapy 39 Radiation 35 Chemoradiotherapy 34 Chemotherapy, Adjuvant 33 Panitumumab 25 XELOX 22 Radiotherapy, Intensity-Modulated 22 Magnetic Resonance Spectroscopy 19 Proctectomy 17 Laparoscopy 16 Floxuridine 16 Immunohistochemistry 15 Surveys and Questionnaires 14 Biopsy 14 pembrolizumab 13 IFL protocol 13 Early Intervention, Educational 13 trifluridine tipiracil drug combination 12 Nivolumab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05576480 2025-08-28

SPARC

Ruijin Hospital

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡